Glucocorticoid deficiency 1
(Redirected from ACTH resistance)
Glucocorticoid deficiency 1 is a rare endocrine disorder characterized by the body's inability to produce sufficient amounts of glucocorticoids, which are essential steroid hormones produced by the adrenal cortex. This condition can lead to a variety of symptoms and health complications due to the critical role glucocorticoids play in regulating metabolism, immune response, and stress response.
Causes[edit | edit source]
Glucocorticoid deficiency 1 is primarily caused by mutations in the MC2R gene (also known as the ACTH receptor gene), which encodes the melanocortin 2 receptor. This receptor is crucial for the stimulation of the adrenal cortex by adrenocorticotropic hormone (ACTH), leading to the production of glucocorticoids. Mutations in this gene disrupt normal receptor function, resulting in impaired glucocorticoid synthesis.
Symptoms[edit | edit source]
The symptoms of glucocorticoid deficiency 1 can vary widely but often include:
- Hypoglycemia (low blood sugar)
- Fatigue
- Weight loss
- Muscle weakness
- Nausea and vomiting
- Hypotension (low blood pressure)
- Increased susceptibility to infections
Diagnosis[edit | edit source]
Diagnosis of glucocorticoid deficiency 1 typically involves a combination of clinical evaluation, laboratory tests, and genetic testing. Key diagnostic steps include:
- Measurement of serum cortisol levels
- ACTH stimulation test
- Genetic testing to identify mutations in the MC2R gene
Treatment[edit | edit source]
The primary treatment for glucocorticoid deficiency 1 is glucocorticoid replacement therapy. This involves the administration of synthetic glucocorticoids, such as hydrocortisone or prednisone, to compensate for the body's deficiency. The dosage and frequency of administration are tailored to the individual patient's needs.
Prognosis[edit | edit source]
With appropriate treatment, individuals with glucocorticoid deficiency 1 can lead relatively normal lives. However, they must be vigilant about managing their condition, particularly during periods of stress or illness, which may require adjustments in their medication.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD